Trevi Therapeutics, Inc.
TRVI
$7.55
$0.060.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.38% | 41.80% | 29.71% | -26.30% | -26.19% |
| Total Receivables | -- | -- | 9.69% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.11% | -52.56% | -74.07% | -70.88% | -39.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -10.48% | -48.13% | -28.72% | -63.48% | -60.12% |
| Total Current Assets | 187.30% | 37.59% | 24.99% | -28.33% | -27.30% |
|
|
|||||
| Total Current Assets | 187.30% | 37.59% | 24.99% | -28.33% | -27.30% |
| Net Property, Plant & Equipment | -25.92% | -22.94% | -21.17% | -20.05% | -16.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -75.09% | -22.51% | -18.18% | -13.80% | 301.47% |
| Total Assets | 182.26% | 36.21% | 24.05% | -28.14% | -26.90% |
|
|
|||||
| Total Accounts Payable | 96.82% | -32.72% | 88.72% | 28.50% | 11.76% |
| Total Accrued Expenses | 21.27% | 81.88% | 83.61% | 98.95% | 60.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -7.44% | -14.29% | -6.86% | 1.71% | 11.55% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 36.86% | 30.14% | 80.44% | 76.36% | 43.32% |
|
|
|||||
| Total Current Liabilities | 36.86% | 30.14% | 80.44% | 76.36% | 43.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.56% | -28.24% | -27.62% | -26.68% | -25.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.94% | 21.24% | 64.18% | 58.11% | 29.34% |
|
|
|||||
| Common Stock & APIC | 54.62% | 23.05% | 20.18% | 4.15% | 3.04% |
| Retained Earnings | -18.03% | -18.94% | -20.04% | -19.16% | -17.34% |
| Treasury Stock & Other | 128.57% | 208.96% | 310.34% | 164.06% | 66.13% |
| Total Common Equity | 199.96% | 37.50% | 20.71% | -34.19% | -30.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 199.96% | 37.50% | 20.71% | -34.19% | -30.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 199.96% | 37.50% | 20.71% | -34.19% | -30.40% |
|
|
|||||